Detalhe da pesquisa
1.
Understanding T cell phenotype for the design of effective chimeric antigen receptor T cell therapies.
J Immunother Cancer
; 9(5)2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34035114
2.
Primary and metastatic breast tumors cross-talk to influence immunotherapy responses.
Oncoimmunology
; 9(1): 1802979, 2020 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32939322
3.
Chimeric antigen receptor-engineered T cells as oncolytic virus carriers.
Mol Ther Oncolytics
; 2: 15014, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-27119109